ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes

Josefin Skogsberg, Andrea Dicker, Mikael Rydén et al. · 2008

Read ApoB100-LDL Acts as a Metabolic Signal from Liver to Peripheral Fat Causing Inhibition of Lipolysis in Adipocytes by Josefin Skogsberg, Andrea Dicker, Mikael Rydén et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003771.txt.

Description

Josefin Skogsberg, Andrea Dicker, Mikael Rydén, and colleagues published this metabolism study in PLOS ONE in 2008. Fat tissue sends fatty acids to the liver, where they shape the making of ApoB-carrying lipoproteins. Whether a signal also travels back from liver to fat was unknown. The team investigated that reverse arm.

They found ApoB100-LDL, the so-called bad cholesterol particle, acts as a metabolic signal to peripheral fat. It inhibits lipolysis, the release of fatty acids from fat cells. The reverse message completes a two-way conversation between the liver and adipose tissue about energy stores.

Catalog record

CREATORJosefin Skogsberg, Andrea Dicker, Mikael Rydén et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003771

Browse the full library · About the Tower of Babel